Загрузка...

Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis

PURPOSE: Although pirfenidone (PFD) is a key drug for the treatment of idiopathic pulmonary fibrosis (IPF), differences in tolerability between elderly and young patients remain unclear. This study aimed to investigate age-related differences in adverse drug reactions to PFD and to evaluate whether...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drug Des Devel Ther
Главные авторы: Sakayori, Masashi, Terada, Jiro, Abe, Mitsuhiro, Hirasawa, Yasutaka, Suzuki, Kenichi, Yoshioka, Keiichiro, Tsushima, Kenji, Tatsumi, Koichiro
Формат: Artigo
Язык:Inglês
Опубликовано: Dove 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6630358/
https://ncbi.nlm.nih.gov/pubmed/31371923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S208733
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!